Gainers
- Novavax, Inc. (NASDAQ:NVAX) shares increased by 71.2% to $9.83 during Tuesday's pre-market session.
- Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares increased by 28.0% to $1.37.
- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) stock moved upwards by 22.5% to $4.03. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares rose 13.7% to $3.16. According to the most recent rating by Bank of America, on November 15, the current rating is at Buy.
- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) shares moved upwards by 13.5% to $2.60.
- NeuroMetrix, Inc. (NASDAQ:NURO) shares rose 8.7% to $4.63.
- Kamada, Inc. (NASDAQ:KMDA) shares increased by 7.5% to $7.01.
- Aethlon Medical, Inc. (NASDAQ:AEMD) shares surged 7.3% to $2.21.
- OrganiGram Holdings, Inc. (NASDAQ:OGI) shares increased by 6.1% to $3.46. According to the most recent rating by Raymond James, on January 09, the current rating is at Market Perform.
- Galapagos, Inc. (NASDAQ:GLPG) stock increased by 5.1% to $239.23. According to the most recent rating by JP Morgan, on January 06, the current rating is at Neutral.
- Aphria, Inc. (NYSE:APHA) shares surged 5.0% to $5.54. According to the most recent rating by CiBC, on January 15, the current rating is at Neutral.
- Cerus, Inc. (NASDAQ:CERS) stock moved upwards by 4.4% to $4.25. According to the most recent rating by BTIG Research, on November 13, the current rating is at Buy.
- Proteostasis Therapeutics, Inc. (NASDAQ:PTI) stock surged 3.1% to $2.02.
- Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) shares rose 3.0% to $0.52. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
- Achieve Life Sciences, Inc. (NASDAQ:ACHV) stock moved upwards by 1.9% to $0.65.
- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) stock rose 1.8% to $0.34.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Losers
- Tonix Pharmaceuticals, Inc. (NASDAQ:TNXP) stock declined 9.7% to $1.40 during Tuesday's pre-market session.
- Seneca Biopharma, Inc. (NASDAQ:SNCA) shares decreased by 8.1% to $1.47.
- Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shares fell 7.4% to $52.25. According to the most recent rating by Oppenheimer, on December 13, the current rating is at Perform.
- AstraZeneca, Inc. (NYSE:AZN) shares decreased by 2.1% to $50.24. The most recent rating by Cowen & Co., on December 02, is at Outperform, with a price target of $55.00.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.